Manufacturing of Viral Gene Therapies
- PMID: 34196319
- DOI: 10.1097/IIO.0000000000000362
Manufacturing of Viral Gene Therapies
References
-
- Shahryari A, Saghaerian JM, Mohammadi S, et al. Development and clinical translation of approved gene therapy products for genetic disorders. Front Genet. 2019;10:868.
-
- Wright JF. Transient Transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther. 2009;20:698–706.
-
- Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998;72:2224–2232.
-
- Grimm D, Kay MA, Kleinschmidt JA. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther. 2003;7:839–850.
-
- Powers AD, Piras BA, Clark RK, et al. Development and optimization of AAV hFIX particles by transient transfection in an iCELLis(®) fixed-bed bioreactor. Hum Gene Ther Methods. 2016;27:112–121.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources